5 ways to use AI for Supply Chain Resilience in Pharmaceutical Businesses
The pharmaceutical supply chain has been subjected to its most significant pressure test in recent years, prompting those who manage supply chains to question the resilience of their own. Hit by the same delays, logjams and price-hikes as other sectors due to COVID19, Pharma supply chains also felt the burden of moving medical equipment and vaccines around the world quickly.
Even in pre-pandemic times, the pharmaceutical supply chain was fast becoming more global and complex, highlighting the need to withstand shocks and minimise risk. Digitisation is key to resilience, moving from a network of manual, siloed systems to a formula that puts real-time visibility and centralisation first, leading to operating efficiencies.
New and emerging technologies enable digitisation while helping to maintain the balance of driving growth and managing costs. One area in particular that can have a real and immediate impact is Artificial Intelligence (AI). Here are five areas within the pharmaceutical supply chain where AI can build resilience.